サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1578283

鎮咳薬の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2024年～2032年）

Global Antitussive Drugs Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日
ページ情報
英文 117 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
鎮咳薬の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2024年～2032年）
出版日: 2024年09月01日
発行: Value Market Research
ページ情報: 英文 117 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の鎮咳薬の市場規模は、2023年の14億9,551万米ドルから、2032年には約23億7,427万米ドル近くに達し、調査期間2024年～2032年のCAGRは5.27%と推定されます。

鎮咳薬は、一般に呼吸器疾患を患う患者の空咳を抑えるために使用される異種薬剤のクラス別です。鎮咳薬は、風邪、インフルエンザ、アレルギー、花粉症、あるいは副鼻腔炎、気管支炎などの呼吸器疾患によって引き起こされる様々な症状を治療することができます。これらの薬剤は、脳の咳中枢に作用することで、患者の咳の衝動を抑えます。これらの薬剤は、フォルコジン、コデイン、デキストロメトルファンなどのオピエートまたはオピオイドです。市販の鎮咳薬で最も使用されているのはデキストロメトルファンで、比較的安全です。経口投与され、シロップ、錠剤、蒸気の形で入手できます。これらの薬は乱用の危険性があり、中毒を引き起こす可能性もあるため、長期使用には適していません。

市場力学

大気汚染の割合が高く、世界人口の間で呼吸器疾患の有病率が高まっていることが、咳止め薬市場の成長の中心的な刺激要因となっています。個々の咳は伝染しやすく、咳は重大なアンメット・メディカル・ニーズであるため、市場の成長はさらに促進されます。咳が続くと生活の質が損なわれるため、鎮咳薬の需要は着実に増加すると思われます。鎮咳薬の認知度が高まり、簡単に入手できるようになれば、市場成長にプラスに働くと思われます。

この調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、鎮咳薬の世界市場における各セグメントを包括的に評価することもできます。鎮咳薬業界の成長と動向は、この調査への全体的なアプローチを提供します。

市場セグメンテーション

鎮咳薬市場レポートのこのセクションでは、国別および地域別のセグメントに関する詳細なデータを提供することで、戦略担当者がそれぞれの製品またはサービスのターゲット層を特定し、今後のビジネスチャンスに役立てることができます。

地域分析

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカの地域展望をカバーし、鎮咳薬市場の現在と将来の需要を明らかにしています。さらに、すべての主要地域における個々の用途セグメントの需要・推定・予測にも焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 鎮咳薬- 産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 鎮咳薬の世界市場分析：症状別

  • 症状別の概要
  • 実績データと予測データ
  • 症状別の分析
  • 疼痛
  • 風邪
  • 咳
  • その他

第6章 鎮咳薬の世界市場分析：薬剤クラス別

  • 薬剤クラス別の概要
  • 実績データと予測データ
  • 薬剤クラス別の分析
  • 末梢性作用薬
  • 中枢作用薬
  • その他

第7章 鎮咳薬の世界市場分析：薬剤別

  • 薬剤別の概要
  • 実績データと予測データ
  • 薬剤別の分析
  • デキストロメトルファン
  • ベンゾナテート

第8章 鎮咳薬の世界市場分析：剤形別

  • 剤形別の概要
  • 実績データと予測データ
  • 剤形別の分析
  • 錠剤
  • シロップ剤
  • その他

第9章 鎮咳薬の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米の売上分析
    • 概要・実績・予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州の売上分析
    • 概要・実績・予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋の売上分析
    • 概要・実績・予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋
  • ラテンアメリカの売上分析
    • 概要・実績・予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカの売上分析
    • 概要・実績・予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ

第10章 鎮咳薬企業の競合情勢

  • 鎮咳薬の市場競合
  • 提携・協力・協定
  • 合併・買収
  • 新製品発売
  • その他の開発

第11章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Pfizer Inc.
  • Johnson & Johnson
  • Sanofi S.A.
  • GlaxoSmithKline Plc
  • Merck & Co. Inc.
  • Novartis International AG
  • AstraZeneca Plc
  • Boehringer Ingelheim International GmbH
  • Roche Holding AG
  • Bayer AG
  • Teva Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Cipla Ltd.
  • Reckitt Benckiser Group Plc
  • Perrigo Company Plc
  • Glenmark Pharmaceuticals Ltd
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Indication (USD MN)
  • Pain Market Sales By Geography (USD MN)
  • Cold Market Sales By Geography (USD MN)
  • Cough Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Drug Class (USD MN)
  • Peripherally Acting Drugs Market Sales By Geography (USD MN)
  • Centrally Acting Drugs Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Drug (USD MN)
  • Dextromethorphan Market Sales By Geography (USD MN)
  • Benzonatate Market Sales By Geography (USD MN)
  • Analysis By Dosage Form (USD MN)
  • Tablets Market Sales By Geography (USD MN)
  • Syrup Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Antitussive Drugs Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Antitussive Drugs Report
  • Market Research Process
  • Market Research Methodology
  • Global Antitussive Drugs Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Indication
  • Market Attractiveness Analysis By Drug Class
  • Market Attractiveness Analysis By Drug
  • Market Attractiveness Analysis By Dosage Form
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Indication (USD MN)
  • Pain Market Sales By Geography (USD MN)
  • Cold Market Sales By Geography (USD MN)
  • Cough Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Drug Class (USD MN)
  • Peripherally Acting Drugs Market Sales By Geography (USD MN)
  • Centrally Acting Drugs Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Drug (USD MN)
  • Dextromethorphan Market Sales By Geography (USD MN)
  • Benzonatate Market Sales By Geography (USD MN)
  • Global Market Analysis By Dosage Form (USD MN)
  • Tablets Market Sales By Geography (USD MN)
  • Syrup Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11213977

The global demand for Antitussive Drugs Market is presumed to reach the market size of nearly USD 2374.27 Million by 2032 from USD 1495.51 Million in 2023 with a CAGR of 5.27% under the study period 2024-2032.

Antitussive drugs are a class of heterogeneous medications generally used to suppress dry cough in patients suffering from respiratory disorders. Antitussive drugs can cure various symptoms caused by the common cold, flu, allergies, hay fever, or other breathing disorders like sinusitis, bronchitis, etc. These drugs reduce the urge to cough in patients by acting on the cough center in the brain. They are either opiates or opioids like pholcodine, codeine, and dextromethorphan. One of the most used over-the-counter antitussive drugs is Dextromethorphan, and it is relatively safe. They are taken orally and are available in the form of syrup, tablets, or vapor. These drugs are not suitable for long-term use since they risk abuse and may even cause addiction.

MARKET DYNAMICS

A high rate of atmospheric pollution and the growing prevalence of respiratory disorders among the global population is the central stimulant for the growth of the cough suppressants market. The contagious nature of individual coughs and cough being a significant unmet medical need will further propel market growth. The demand for antitussive drugs will see a steady increase since persistent cough can harm a person's quality of life. Rising awareness and easy availability of these drugs will benefit market growth. Continuing research to produce cheap, effective cough suppressants with minimal side effects will hinder this market's growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Antitussive Drugs. The growth and trends of Antitussive Drugs industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Antitussive Drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Indication

  • Pain
  • Cold
  • Cough
  • Others

By Drug Class

  • Peripherally Acting Drugs
  • Centrally Acting Drugs
  • Others

By Drug

  • Dextromethorphan
  • Benzonatate

By Dosage Form

  • Tablets
  • Syrup
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Antitussive Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Antitussive Drugs market include Pfizer Inc., Johnson & Johnson, Sanofi S.A., GlaxoSmithKline Plc, Merck & Co. Inc., Novartis International AG, AstraZeneca Plc, Boehringer Ingelheim International GmbH, Roche Holding AG, Bayer AG, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Mylan N.V., Cipla Ltd., Reckitt Benckiser Group Plc, Perrigo Company Plc, Glenmark Pharmaceuticals Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. ANTITUSSIVE DRUGS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Indication
    • 3.7.2 Market Attractiveness Analysis By Drug Class
    • 3.7.3 Market Attractiveness Analysis By Drug
    • 3.7.4 Market Attractiveness Analysis By Dosage Form
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL ANTITUSSIVE DRUGS MARKET ANALYSIS BY INDICATION

  • 5.1. Overview By Indication
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Indication
  • 5.4. Pain Historic and Forecast Sales By Regions
  • 5.5. Cold Historic and Forecast Sales By Regions
  • 5.6. Cough Historic and Forecast Sales By Regions
  • 5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL ANTITUSSIVE DRUGS MARKET ANALYSIS BY DRUG CLASS

  • 6.1. Overview By Drug Class
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Drug Class
  • 6.4. Peripherally Acting Drugs Historic and Forecast Sales By Regions
  • 6.5. Centrally Acting Drugs Historic and Forecast Sales By Regions
  • 6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL ANTITUSSIVE DRUGS MARKET ANALYSIS BY DRUG

  • 7.1. Overview By Drug
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Drug
  • 7.4. Dextromethorphan Historic and Forecast Sales By Regions
  • 7.5. Benzonatate Historic and Forecast Sales By Regions

8. GLOBAL ANTITUSSIVE DRUGS MARKET ANALYSIS BY DOSAGE FORM

  • 8.1. Overview By Dosage Form
  • 8.2. Historical and Forecast Data
  • 8.3. Analysis By Dosage Form
  • 8.4. Tablets Historic and Forecast Sales By Regions
  • 8.5. Syrup Historic and Forecast Sales By Regions
  • 8.6. Others Historic and Forecast Sales By Regions

9. GLOBAL ANTITUSSIVE DRUGS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE ANTITUSSIVE DRUGS COMPANIES

  • 10.1. Antitussive Drugs Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF ANTITUSSIVE DRUGS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Pfizer Inc.
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Johnson & Johnson
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Sanofi S.A.
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. GlaxoSmithKline Plc
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Merck & Co. Inc.
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Novartis International AG
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. AstraZeneca Plc
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Boehringer Ingelheim International GmbH
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Roche Holding AG
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Bayer AG
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. Teva Pharmaceutical Industries Ltd.
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. Sun Pharmaceutical Industries Ltd.
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments
  • 11.15. Mylan N.V.
    • 11.15.1 Company Overview
    • 11.15.2 Company Revenue
    • 11.15.3 Products
    • 11.15.4 Recent Developments
  • 11.16. Cipla Ltd.
    • 11.16.1 Company Overview
    • 11.16.2 Company Revenue
    • 11.16.3 Products
    • 11.16.4 Recent Developments
  • 11.17. Reckitt Benckiser Group Plc
    • 11.17.1 Company Overview
    • 11.17.2 Company Revenue
    • 11.17.3 Products
    • 11.17.4 Recent Developments
  • 11.18. Perrigo Company Plc
    • 11.18.1 Company Overview
    • 11.18.2 Company Revenue
    • 11.18.3 Products
    • 11.18.4 Recent Developments
  • 11.19. Glenmark Pharmaceuticals Ltd
    • 11.19.1 Company Overview
    • 11.19.2 Company Revenue
    • 11.19.3 Products
    • 11.19.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies